Addressing Smokeless Tobacco and building Research Capacity in South Asia - ASTRA

ational Institute of Health Research UK0 sites0 target enrollmentStarted: TBDLast updated: November 24, 2021

Trial Snapshot

No summary available.

•1.Self-reported daily users of ST products at least for the last 6 months or ST use on >25 days in the past month
•2.Able to provide informed consent
•3.Motivated and willing to quit ST use within the next 30 days

•1.Self-reported users of any combustible tobacco product (cigarettes, bidis, hookah) or e-cigarettes in the past 30 days or those having Carbon monoxide (CO) levels >10ppm, identified by a breath test.
•2.Pregnant or breastfeeding women.
•3.Individuals with health conditions, which warrant caution in using NRT and have previously been excluded in trials of nicotine replacement in smoking. These will be assessed by participant self-report at the pre-trial screening by asking participants whether they have suffered angina pectoris, myocardial infarction or stroke the past three weeks.
•4.Individuals who are already on an existing treatment, either pharmacological or behavioral, for tobacco cessation.
•5.ST using individuals with diagnosis or oral cancer. Due to the nature of care required, any such individuals identified during the recruitment process will receive a direct referral to specialist care for treatment.

Sponsor

ational Institute of Health Research UK